Chronic hepatic failure, or end-stage liver disease, represents the final chapter in a long journey of liver damage—a point where the body’s hardest-working filter can no longer keep up with its essential duties. Treatment at this stage is about managing complications, slowing further harm, and, for many, preparing for the possibility of a liver transplant.

When the Liver Can No Longer Keep Up: Treatment Goals

Treating chronic hepatic failure is fundamentally different from treating many other diseases. The liver, after years of inflammation and scarring, has reached a stage where its ability to perform vital functions—filtering toxins, producing proteins needed for blood clotting, making bile for digestion—is severely compromised. At this point, treatment cannot reverse the permanent damage, but it can address the complications that arise and improve a patient’s quality of life.^[1]

The goals of treatment depend heavily on how far the disease has progressed and the individual patient’s overall health. For some, the focus is on controlling symptoms like fluid buildup in the abdomen, confusion caused by toxins reaching the brain, or bleeding from enlarged veins. For others, especially those with decompensated cirrhosis—when the body can no longer compensate for the liver’s failing functions—the definitive treatment is a liver transplant.^[6] In between these extremes, medical teams work to slow the progression of damage, manage the underlying causes of liver disease (such as viral hepatitis or alcohol use), and prevent life-threatening complications.^[2]

Treatment strategies are guided by established clinical guidelines from medical societies, which recommend regular monitoring through blood tests, imaging, and physical exams. Healthcare teams typically include liver specialists (hepatologists), transplant surgeons, dietitians, and nurses with expertise in liver disease. This coordinated approach ensures that all aspects of a patient’s condition are addressed.^[7]

Standard Medical Treatments for Chronic Liver Failure

Standard treatment for chronic hepatic failure is largely focused on managing the complications that develop as the liver loses its ability to function. Because the scarring (cirrhosis) that defines this stage is irreversible, medications and interventions aim to keep the patient as stable and comfortable as possible while addressing specific problems as they arise.^[12]

One of the most common complications is ascites, the buildup of fluid in the abdomen. This occurs because the damaged liver cannot produce enough of a protein called albumin, and because blood pressure increases in the veins leading to the liver. Treatment typically begins with a low-sodium diet—patients are often advised to consume less than 2 grams of salt per day—to reduce fluid retention. When diet alone is insufficient, doctors prescribe diuretics, medications that help the body eliminate excess water. The most commonly used diuretics are spironolactone and furosemide, which work together to reduce swelling without causing dangerous shifts in blood chemistry. In severe cases, a procedure called paracentesis is performed: a needle is inserted into the abdomen to drain large volumes of fluid, providing rapid relief.^[7]

Another serious complication is hepatic encephalopathy, a condition where toxins (especially ammonia) build up in the blood and affect brain function. Patients may experience confusion, drowsiness, personality changes, or even lose consciousness. The standard treatment is a medication called lactulose, a synthetic sugar that works by trapping ammonia in the colon so it can be expelled in the stool. Patients typically take lactulose several times a day, adjusting the dose to achieve two to three soft bowel movements daily. Another option is rifaximin, an antibiotic that reduces the number of ammonia-producing bacteria in the gut. These medications are often used together and may need to be continued indefinitely.^[7]

Bleeding from esophageal varices—enlarged, fragile veins in the esophagus caused by increased pressure in the liver’s blood vessels—is another life-threatening complication. To prevent bleeding, doctors may prescribe beta-blockers such as propranolol or nadolol, which lower the pressure in these veins. For patients who have already experienced bleeding, an emergency procedure called endoscopic band ligation may be necessary: a flexible tube with a camera is inserted through the mouth, and small rubber bands are placed around the varices to stop the bleeding. Some patients may also require a procedure called TIPS (transjugular intrahepatic portosystemic shunt), where a small tube is placed inside the liver to redirect blood flow and reduce pressure.^[15]

Treating the underlying cause of liver disease is equally important. For patients with chronic hepatitis B or C, antiviral medications can suppress the virus and prevent further liver damage. For those with alcohol-related liver disease, complete and permanent abstinence from alcohol is essential; support programs and addiction specialists play a critical role. Patients with metabolic dysfunction-associated steatotic liver disease (formerly called fatty liver disease) benefit from weight loss, improved diet, and control of diabetes and high cholesterol.^[10]

Nutritional support is a cornerstone of treatment. Many patients with advanced liver disease become malnourished because they lose their appetite, feel full quickly, or have difficulty absorbing nutrients. Dietitians recommend eating small, frequent meals throughout the day and increasing protein intake to prevent muscle wasting. However, protein intake must be carefully balanced in patients with hepatic encephalopathy. In some cases, nutritional supplements or vitamins (especially vitamin K, which helps with blood clotting) may be prescribed.^[11]

Patients are also monitored regularly for liver cancer (hepatocellular carcinoma), as those with cirrhosis are at high risk. Screening typically involves an abdominal ultrasound and a blood test for a protein called alpha-fetoprotein every six months.^[7]

The duration of these treatments varies. Some, like diuretics and lactulose, may be needed for the rest of a patient’s life or until they receive a liver transplant. Others, like antibiotics for infections, are short-term. Side effects are common: diuretics can cause dehydration, low potassium, or kidney problems; lactulose often causes diarrhea and cramping; beta-blockers may lower blood pressure too much or cause fatigue. Close monitoring by healthcare providers is essential to adjust doses and manage side effects.^[15]

Liver Transplantation: The Definitive Treatment

For many patients with chronic hepatic failure, a liver transplant represents the only chance at long-term survival. When the liver can no longer perform its essential functions despite medical treatment, transplantation becomes the definitive therapy. This is especially true for patients with decompensated cirrhosis, where complications like uncontrolled fluid buildup, repeated episodes of confusion, or bleeding from varices significantly reduce life expectancy.^[6]

The process of getting a liver transplant begins with a comprehensive evaluation, which can take several days to weeks. During this time, medical teams assess whether the patient is healthy enough for major surgery and whether the transplant is likely to be successful. Tests include blood work, imaging scans, heart and lung evaluations, and psychological assessments. Patients must also demonstrate that they can adhere to the strict medication regimen required after transplant and, in cases of alcohol-related liver disease, prove they have maintained sobriety.^[14]

Once approved, patients are placed on a waiting list. The wait time depends on the severity of the patient’s condition (measured by a scoring system called the MELD score, which predicts short-term mortality), their blood type, and the availability of donor organs. Some patients wait weeks; others wait years. During this time, their condition is monitored closely, and they receive ongoing medical treatment to manage symptoms and prevent complications.^[6]

Liver transplant surgery is a complex, lengthy operation. The diseased liver is removed and replaced with a healthy liver from a deceased donor or, in some cases, a portion of a liver from a living donor (usually a family member). After surgery, patients spend time in intensive care and then in a regular hospital ward, typically for one to two weeks. Recovery involves taking immunosuppressive medications to prevent the body from rejecting the new liver. These medications must be taken for life and require regular blood tests to monitor levels and adjust doses.^[14]

Transplantation is not without risks. Surgery can lead to bleeding, infection, or complications from anesthesia. The new liver may not function properly immediately, or the body may reject it. Long-term use of immunosuppressive drugs increases the risk of infections and certain cancers. However, for patients with end-stage liver disease, transplantation offers the best chance of survival and a return to a relatively normal life. Many transplant recipients live for decades after surgery.^[14]

Innovative Treatments Being Tested in Clinical Trials

While standard treatments manage the symptoms and complications of chronic hepatic failure, researchers are actively exploring new therapies that could alter the course of the disease or even regenerate damaged liver tissue. These experimental treatments are being evaluated in clinical trials, and while they offer hope, they are not yet widely available or proven to be effective.

One area of active investigation is liver dialysis, a technology designed to temporarily take over some of the liver’s functions while it heals or while a patient waits for a transplant. The most well-known system is called MARS (Molecular Adsorbent Recirculating System), a machine that filters the blood to remove toxins and harmful substances that the failing liver cannot eliminate. MARS works by circulating the patient’s blood through a special membrane that binds protein-bound and water-soluble toxins, including ammonia, which can affect brain function. This technology is primarily used in patients with acute liver failure, but some centers are testing its use in chronic liver failure patients with severe complications. Early studies suggest that MARS can improve symptoms like confusion and reduce the levels of toxins in the blood, but it is not a cure—it serves as a bridge to transplantation or recovery.^[14]

Another promising avenue is cell-based therapies, which aim to regenerate damaged liver tissue. Researchers are exploring the use of hepatic stem cells—special cells that can develop into functional liver cells (hepatocytes). The idea is to inject these cells into the liver or bloodstream, where they could potentially replace damaged cells and restore some liver function. This approach is still in the early stages of research, with most trials in Phase I or Phase II, focusing on safety and preliminary efficacy. While animal studies have shown encouraging results, it is not yet clear whether stem cell therapy will be effective in humans with chronic liver disease. Trials are ongoing in the United States, Europe, and Asia, with strict eligibility criteria—patients typically must have advanced cirrhosis but still be stable enough to participate.^[2]

Researchers are also investigating drugs that could slow or even reverse liver fibrosis (scarring). One example is therapies targeting stellate cells, which are responsible for producing scar tissue in the liver. When the liver is injured, these cells become activated and lay down collagen, leading to fibrosis and eventually cirrhosis. Experimental drugs aim to block the signaling pathways that activate stellate cells or promote the breakdown of existing scar tissue. These agents are being tested in Phase II and Phase III clinical trials, often in patients with earlier stages of liver disease (before cirrhosis sets in), as preventing fibrosis is easier than reversing it. Specific molecules being studied include compounds that inhibit enzymes involved in collagen production or target inflammatory pathways that drive fibrosis.^[2]

Gene therapy is another frontier. Scientists are exploring ways to introduce healthy genes into liver cells to correct genetic defects that cause certain types of liver disease, such as hemochromatosis or Wilson’s disease. While these conditions are not the most common causes of chronic liver failure, advances in gene therapy could eventually be applied to more prevalent forms of liver disease. These trials are in very early phases, primarily Phase I, and are focused on ensuring the safety of the genetic modification techniques.

For patients with liver disease caused by metabolic dysfunction (such as fatty liver disease), several drugs are being tested that target the underlying metabolic abnormalities. For example, FXR agonists (farnesoid X receptor agonists) are medications that regulate bile acid metabolism and reduce fat accumulation in the liver. These drugs are in Phase III trials, meaning they are being compared directly with standard treatments or placebo in large groups of patients. Early results suggest they can reduce liver inflammation and fibrosis, but long-term effectiveness and safety data are still being gathered. Other investigational drugs include PPAR agonists (peroxisome proliferator-activated receptor agonists), which influence fat metabolism and insulin sensitivity, and ACC inhibitors (acetyl-CoA carboxylase inhibitors), which block the production of fat in the liver.^[2]

Clinical trials for chronic hepatic failure are being conducted in major medical centers around the world, including in the United States, Europe (particularly Germany, France, and the United Kingdom), and increasingly in Asia. Patients interested in participating must meet specific criteria, such as having a certain stage of liver disease, being within a particular age range, and not having other serious health conditions. Trials are typically free for participants, and many cover the costs of tests and medications. However, participation requires a commitment to frequent visits, monitoring, and sometimes invasive procedures.^[2]

Most common treatment methods

• Medications for complications
  • Diuretics such as spironolactone and furosemide to reduce fluid buildup in the abdomen and legs
  • Lactulose and rifaximin to manage confusion and brain fog caused by toxin buildup
  • Beta-blockers like propranolol to prevent bleeding from enlarged veins in the esophagus
  • Antiviral drugs for patients with hepatitis B or C to suppress the virus and slow liver damage
• Dietary and lifestyle modifications
  • Low-sodium diet to control fluid retention
  • Small, frequent meals with adequate protein to prevent malnutrition and muscle loss
  • Complete abstinence from alcohol
  • Weight management and control of diabetes and cholesterol for metabolic liver disease
• Procedures for managing complications
  • Paracentesis to drain large amounts of fluid from the abdomen
  • Endoscopic band ligation to stop or prevent bleeding from esophageal varices
  • TIPS (transjugular intrahepatic portosystemic shunt) to reduce pressure in liver blood vessels
• Liver transplantation
  • Comprehensive evaluation to determine transplant eligibility
  • Placement on a waiting list based on disease severity and blood type
  • Surgery to replace the failing liver with a healthy donor liver
  • Lifelong immunosuppressive medications to prevent rejection
• Experimental treatments in clinical trials
  • Liver dialysis using systems like MARS to remove toxins from the blood
  • Stem cell therapy to regenerate damaged liver tissue
  • Anti-fibrotic drugs targeting stellate cells to slow or reverse scarring
  • Metabolic drugs such as FXR agonists and ACC inhibitors to reduce liver fat and inflammation
  • Gene therapy for genetic liver diseases